Reversal by physostigmine of clozapine-induced delirium

Clinical Toxicology

Volumn 10, Issue 4, 1977, Pages 437-441

  Schuster, P ^a   Gabriel, E ^a   Kufferle B ^a   Strobl, G ^a   Karobath, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; PHYSOSTIGMINE; PHYSOSTIGMINE SALICYLATE;

ADVERSE DRUG REACTION; AGITATION; CLINICAL STUDY; DELIRIUM; DRUG THERAPY; HALLUCINATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; THERAPY;

ADULT; BIPOLAR DISORDER; CLOZAPINE; DELIRIUM; DIBENZAZEPINES; FEMALE; HUMANS; MALE; PHYSOSTIGMINE;

EID: 0017713263     PISSN: 15563650     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563657709046281     Document Type: Article

References (12)

1. Reversal of delirium induced by tricyclic antidepressant drugs with physostigmine
2. Physostigmine, its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs
3. Efficiency of Tofranil in the treatment of various types of depression
4. Cardiac complications of tricyclic antidepressant therapy
5. Cardiovascular complications of antidepressant therapy
6. Kritische Stellungnahme zum Begriff der Neuroleptika
7. Das Wirkungsprofil eines chemisch neuartigen Breitbandneuroleptikums der Dibenzoazepingruppe
8. Ergebnisse eines Doppelblindversuches von HF 1854 (8-Chlor-11- (4-methyl- 1-piperazinyl)-5H-dibenzo (b, e) (1, 4) diazepin im Vergleich zu Levomeprazin
9. Clozapin bei psychomotorischen Erregungszuständen
10. Antischizophrenic drugs and brain cholinergic receptors
11. Antimuscarinic properties of neuroleptics and drug-induced Parkinsonism
12. Neurolepticinduced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine